These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 10215653)

  • 41. Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms.
    Lan X; Zhao C; Chen X; Zhang P; Zang D; Wu J; Chen J; Long H; Yang L; Huang H; Carter BZ; Wang X; Shi X; Liu J
    J Hematol Oncol; 2016 Nov; 9(1):129. PubMed ID: 27884201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ribozyme-mediated inhibition of a Philadelphia chromosome-positive acute lymphoblastic leukemia cell line expressing the p190 bcr-abl oncogene.
    Snyder DS; Wu Y; McMahon R; Yu L; Rossi JJ; Forman SJ
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):179-86. PubMed ID: 9360779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of phosphorylation of p160 BCR within p210 BCR-ABL complexes during early stages of phorbol ester-induced differentiation of K562 cells.
    Campbell ML; Lu D; Guo JQ; Arlinghaus RB
    Cell Growth Differ; 1993 Jul; 4(7):581-8. PubMed ID: 8398898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA fragmentation induced by protease activation in p53-null human leukemia HL60 cells undergoing apoptosis following treatment with the topoisomerase I inhibitor camptothecin: cell-free system studies.
    Shimizu T; Pommier Y
    Exp Cell Res; 1996 Aug; 226(2):292-301. PubMed ID: 8806433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
    Zhang XM; Lin H; Chen C; Chen BD
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BCR-ABL accelerates C2-ceramide-induced apoptosis.
    Maguer-Satta V; Burl S; Liu L; Damen J; Chahine H; Krystal G; Eaves A; Eaves C
    Oncogene; 1998 Jan; 16(2):237-48. PubMed ID: 9464542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Requirement for Mdm2 in the survival effects of Bcr-Abl and interleukin 3 in hematopoietic cells.
    Goetz AW; van der Kuip H; Maya R; Oren M; Aulitzky WE
    Cancer Res; 2001 Oct; 61(20):7635-41. PubMed ID: 11606405
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beta-hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1).
    Masuda Y; Nishida A; Hori K; Hirabayashi T; Kajimoto S; Nakajo S; Kondo T; Asaka M; Nakaya K
    Oncogene; 2003 Feb; 22(7):1012-23. PubMed ID: 12592388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. mTOR inhibitor RAD001 (Everolimus) enhances the effects of imatinib in chronic myeloid leukemia by raising the nuclear expression of c-ABL protein.
    Mancini M; Corradi V; Petta S; Martinelli G; Barbieri E; Santucci MA
    Leuk Res; 2010 May; 34(5):641-8. PubMed ID: 19643477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancement of CPP32-like activity in the TNF-treated U937 cells by the proteasome inhibitors.
    Fujita E; Mukasa T; Tsukahara T; Arahata K; Omura S; Momoi T
    Biochem Biophys Res Commun; 1996 Jul; 224(1):74-9. PubMed ID: 8694836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular interactions of CRKL, and SH2-SH3 adaptor protein.
    ten Hoeve J; Kaartinen V; Fioretos T; Haataja L; Voncken JW; Heisterkamp N; Groffen J
    Cancer Res; 1994 May; 54(10):2563-7. PubMed ID: 8168080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion.
    Keeshan K; Cotter TG; McKenna SL
    Leukemia; 2002 Sep; 16(9):1725-34. PubMed ID: 12200687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo.
    Chun-Guang W; Jun-Qing Y; Bei-Zhong L; Dan-Ting J; Chong W; Liang Z; Dan Z; Yan W
    Eur J Pharmacol; 2010 Feb; 627(1-3):33-41. PubMed ID: 19857484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity.
    Honma Y; Okabe-Kado J; Hozumi M; Uehara Y; Mizuno S
    Cancer Res; 1989 Jan; 49(2):331-4. PubMed ID: 2910452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apoptosis of Ewing's sarcoma cells is accompanied by accumulation of ubiquitinated proteins.
    Soldatenkov VA; Dritschilo A
    Cancer Res; 1997 Sep; 57(18):3881-5. PubMed ID: 9307264
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of apoptosis by a dominant negative H-RAS mutant (116Y) in K562 cells.
    Sakai N; Ogiso Y; Fujita H; Watari H; Koike T; Kuzumaki N
    Exp Cell Res; 1994 Nov; 215(1):131-6. PubMed ID: 7957661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis.
    Fuchs EJ; Bedi A; Jones RJ; Hess AD
    Cancer Res; 1995 Feb; 55(3):463-6. PubMed ID: 7834607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines.
    Jonuleit T; van der Kuip H; Miething C; Michels H; Hallek M; Duyster J; Aulitzky WE
    Blood; 2000 Sep; 96(5):1933-9. PubMed ID: 10961897
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteasome activation occurs at an early, premitochondrial step of thymocyte apoptosis.
    Hirsch T; Dallaporta B; Zamzami N; Susin SA; Ravagnan L; Marzo I; Brenner C; Kroemer G
    J Immunol; 1998 Jul; 161(1):35-40. PubMed ID: 9647204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Jak2 is involved in c-Myc induction by Bcr-Abl.
    Xie S; Lin H; Sun T; Arlinghaus RB
    Oncogene; 2002 Oct; 21(47):7137-46. PubMed ID: 12370803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.